Exosomal proteomic profiling from specimen-derived blood reveals enriched prognostic biomarkers in colorectal cancer
Translational Oncology · 2027-01 · 75 · 103129
DOI: 10.1016/j.tranon.2026.103129 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Oncology, 2027-01. Verfasst von Mu-qing Yang und 11 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Yang, M., Pan, Y., Lin, Y., Lu, T., Zhang, X., Sheng, S., Yu, T., Ma, B., Ren, H., Liao, X., Chen, C., & Li, J. (2027). Exosomal proteomic profiling from specimen-derived blood reveals enriched prognostic biomarkers in colorectal cancer. Translational Oncology, 75, 103129. https://doi.org/10.1016/j.tranon.2026.103129
Vancouver
Yang M, Pan Y, Lin Y, Lu T, Zhang X, Sheng S, et al. Exosomal proteomic profiling from specimen-derived blood reveals enriched prognostic biomarkers in colorectal cancer. Translational Oncology. 2027;75:103129. doi:10.1016/j.tranon.2026.103129
BibTeX
@article{Yang2027,
author = {Yang, Mu-qing and Pan, Yun and Lin, Yang and Lu, Ting-ting and Zhang, Xian-lin and Sheng, Suyazi and Yu, Tian-yu and Ma, Bing-wei and Ren, Hui and Liao, Xin-yi and Chen, Chun-qiu and Li, Ji-yu},
title = {Exosomal proteomic profiling from specimen-derived blood reveals enriched prognostic biomarkers in colorectal cancer},
journal = {Translational Oncology},
year = {2027},
volume = {75},
pages = {103129},
doi = {10.1016/j.tranon.2026.103129}
}
EUVIMED